[core]
report_id=REV-01-005_Pl-v1

[provenance_helper]
root_sample_name=REVOLVE_0005
study_title=REVTAR
sample_name_whole_genome_normal = None
sample_name_whole_genome_tumour = None
sample_name_whole_transcriptome = None

[case_overview]
primary cancer = peritoneal cancer
site of biopsy/surgery = Plasma
requisition approved = 2023/05/29
study = Re-VOLVE
assay=Targeted Sequencing - REVOLVE Panel - cfDNA and Buffy Coat (v1.0)
blood sample id=REV-01-005_BC
tumour sample id=REV-01-005_Pl
donor=REVOLVE_0005
patient_study_id=REV-01-005
sample_info.json=None

[treatment_options_merger]

[summary]

[tar.sample]
group_id=REV-01-005_Pl
oncotree=PSEC
known_variants=<em>BRCA1</em>

[tar.snv_indel]
tumour_id=REV-01-005_Pl
normal_id=REV-01-005_BC
oncotree_code=PSEC
tcgacode=TCGA_ALL
root_sample_name=REVOLVE_0005
study_title=REVTAR

[tar.swgs]
root_sample_name=REVOLVE_0005
tumour_id=REV-01-005_Pl
oncotree_code=PSEC

[supplement]
assay=TAR